Tumor cells expressing the Erythroid-like signature in patients 2 and 5 expressed early-stage erythroblast markers, but had lower expression of mid and late stage erythroid markers HBG1, HBG2, HBA2, and HBB than tumor-associated erythroid cells. Here, HBG1 is linked to neoplasm.